Clinical Trial Update: Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a continuation protocol for ZEN003694 in patients with metastatic castration-resistant prostate cancer who are experiencing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ZEN003694

Snippet

Sponsor: Zenith Epigenetics | Conditions: mCRPC | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION